Literature DB >> 7545869

L206W mutation of the cystic fibrosis gene, relatively frequent in French Canadians, is associated with atypical presentations of cystic fibrosis.

R Rozen1, L Ferreira-Rajabi, L Robb, N Colman.   

Abstract

Cystic fibrosis is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Over 400 mutations have been reported at this locus. Although severe forms of cystic fibrosis are usually associated with pancreatic insufficiency, pulmonary dysfunction, and elevated sweat chloride, there is a wide range of phenotypes, including congenital absence of the vas deferens, observed with some of the milder mutations. The L206W mutation, which was first identified in patients from South France, is relatively frequent in French Canadians from Quebec. In this report, we document the atypical form of cystic fibrosis associated with this mutation, in a cohort of 7 French Canadian probands.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545869     DOI: 10.1002/ajmg.1320570314

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  3 in total

1.  Thirteen cystic fibrosis patients, 12 compound heterozygous and one homozygous for the missense mutation G85E: a pancreatic sufficiency/insufficiency mutation with variable clinical presentation.

Authors:  C Vazquez; G Antiñolo; T Casals; J Dapena; J Elorz; J L Seculi; J Sirvent; R Cabanas; C Soler; X Estivill
Journal:  J Med Genet       Date:  1996-10       Impact factor: 6.318

2.  Description of rare mutations and a novel variant in Brazilian patients with Cystic Fibrosis: a case series from a referral center in the Bahia State.

Authors:  Laís Ribeiro Mota; Valmir Machado de Melo Filho; Lorena Lemos de Castro; Daniel Fantozzi Garcia; Regina Terse-Ramos; Maria Betânia Pereira Toralles; Renata Lúcia Leite Ferreira de Lima; Edna Lúcia Souza
Journal:  Mol Biol Rep       Date:  2018-09-19       Impact factor: 2.316

3.  Distinct proteostasis states drive pharmacologic chaperone susceptibility for cystic fibrosis transmembrane conductance regulator misfolding mutants.

Authors:  Eli Fritz McDonald; Carleen Mae P Sabusap; Minsoo Kim; Lars Plate
Journal:  Mol Biol Cell       Date:  2022-04-07       Impact factor: 3.612

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.